Literature DB >> 406928

Inhibition of amino acyl tRNA synthetase activity by copper complexes of two metal binding ligands. N-Methyl isatin beta-thiosemicarbazone and 8-hydroxyquinoline.

W Rohde, B Cordell, R Webster, W Levinson.   

Abstract

Copper complexes of N-methyl isatin beta-thiosemicarbazone, 1-formyl isoquinoline thiosemicarbazone and thiosemicarbazide inhibit amino acyl tRNA synthetase activity. Copper complexes of 8-hydroxyquinoline and 8-mercaptoquinoline also inhibit. The 1 : 1 ligand-metal complex is significantly more active than the 2 : 1 complex. The free ligand alone and copper sulfate alone have little, if any, effect. These complexes have no effect on the ATP-PPi exchange reaction and do not cause deacylation of amino acyl tRNAs. This indicates that the process inhibited by these complexes is the amino acylation reaction. This is the first report that these copper binding ligands can inhibit enzymatic processes which involve nucleic acids but which are not viral, bacterial or mammalian cell polymerases.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 406928     DOI: 10.1016/0005-2787(77)90226-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  In vitro activities of cloxyquin (5-chloroquinolin-8-ol) against Mycobacterium tuberculosis.

Authors:  Poonpilas Hongmanee; Kamolchanok Rukseree; Benjamas Buabut; Boontiwa Somsri; Prasit Palittapongarnpim
Journal:  Antimicrob Agents Chemother       Date:  2006-12-18       Impact factor: 5.191

2.  A MurF inhibitor that disrupts cell wall biosynthesis in Escherichia coli.

Authors:  Ellen Z Baum; Steven M Crespo-Carbone; Alexandra Klinger; Barbara D Foleno; Ignatius Turchi; Mark Macielag; Karen Bush
Journal:  Antimicrob Agents Chemother       Date:  2007-10-01       Impact factor: 5.191

3.  In vitro Antimicrobial Activity of Chlorquinaldol against Microorganisms Responsible for Skin and Soft Tissue Infections: Comparative Evaluation with Gentamicin and Fusidic Acid.

Authors:  Monica Bortolin; Alessandro Bidossi; Elena De Vecchi; Maura Avveniente; Lorenzo Drago
Journal:  Front Microbiol       Date:  2017-06-08       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.